Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2022
vol. 87 Head and neck radiology
abstract:
Review paper
Imaging spectrum of rhino-orbital-cerebral mucormycosis secondary to COVID-19 infection: a reporting checklist
Yogeshwari Anay Deshmukh
1
,
Sanjay Vaid
2
,
Aparna Chandorkar
1
,
Ashish Atre
3
,
Sunil Patil
1
1.
Star Imaging and Research Centre, Pune, Maharashtra State, India
2.
Head, Neck, and ENT Imaging Division, Star Imaging and Research Centre, Pune, Maharashtra State, India
3.
Neuroradiology and Paediatric Imaging Division, Star Imaging and Research Centre, Pune, Maharashtra State, India
© Pol J Radiol 2022; 87: e333-e347
Online publish date: 2022/06/22
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
In recent times, India has been in the midst of a notifiable epidemic of mucormycosis (a rare angio-invasive fungal infection), within the ongoing global coronavirus disease 2019 (COVID-19) pandemic. Epidemiological studies have reported the estimated prevalence of mucormycosis to be around 70 times higher in India as compared to the global data, even in the pre-COVID era. However, in the last 3 months, our city witnessed an unprecedented surge in cases of post-COVID-19-associated rhino-orbital-cerebral (ROC) mucormycosis.
This pictorial review aims to illustrate the entire imaging spectrum of mucormycosis in the head-neck-face region. Along with the usual sites (nose, paranasal sinuses, orbits), this disease also involves the skull base, palate, temporal bone, and deep neck spaces. Many cases also demonstrated morbid and, at times, fatal intracranial and neurovascular complications. This review also aims to provide a structured reporting template that will prove useful to the radiologists interpreting imaging studies of ROC mucormycosis. keywords:
COVID-19, mucormycosis, rhino-orbital-cerebral, diagnostic imaging |